Science Explorer Back to mapMap
Discussion
Researcher · Kenyon College · United States

LAURA E. ALDRETE

LAURA E. ALDRETE publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Prostate Cancer Treatment and Research, Peptidase Inhibition and Analysis and Heparin-Induced Thrombocytopenia and Thrombosis.

OpenAlex
World rank
#7,710,381
of 7,710,434 ranked researchers
Rank in United States
#1,627,067
of 1,627,098
Works
1,143
Citations
34
h-index
2
i10-index 1Top 99% in Oncology
LAURA E. ALDRETE

What does LAURA E. ALDRETE research?

LAURA E. ALDRETE's work is mostly in Medicine (82%), Pharmacology, Toxicology and Pharmaceutics (13%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 938 works · 82.1% of their workMedicine: 938 works · 82.1% of their workOncology: 413 works · 36.1% of their workPulmonary and Respiratory Medicine: 367 works · 32.1% of their workSurgery: 159 works · 13.9% of their workLife Sciences: 194 works · 17.0% of their workPharmacology, Toxicology and Pharmaceutics: 149 works · 13.0% of their workPharmaceutical Science: 149 works · 13.0% of their workBiochemistry, Genetics and Molecular Biology: 46 works · 4.0% of their workMolecular Biology: 46 works · 4.0% of their workEverything else: 7 works · 0.6% of their workPhysical Sciences: 3 works · 0.3% of their workEngineering: 3 works · 0.3% of their workAerospace Engineering: 3 works · 0.3% of their workTHEIR WORKLAURA E. ALDRETE1,143works
Life Sciences17%Physical Sciences0%Health Sciences82%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine93882.1%
    1. Pharmacology, Toxicology and Pharmaceutics14913.0%
    2. Biochemistry, Genetics and Molecular Biology464.0%
  3. Everything else70.6%
    1. Engineering30.3%
  1. 1Oncology36% of their works
  2. 2Pulmonary and Respiratory Medicine32% of their works
  3. 3Surgery14% of their works
  4. 4Pharmaceutical Science13% of their works
  5. 5Molecular Biology4% of their works
  6. 6Aerospace Engineering0% of their works

Research topics

Which keywords describe LAURA E. ALDRETE's research?

The keywords of their largest research topics: Cancer Therapy, Androgen Receptor, Prostate Cancer, Fibroblast Activation Protein, Tumor Microenvironment, Heparin-Induced Thrombocytopenia, Thrombosis and Deuterium.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer Therapy1,2362 topics
  2. Androgen Receptor1,1001 topic
  3. Prostate Cancer1,1001 topic
  4. Fibroblast Activation Protein1,0711 topic
  5. Tumor Microenvironment1,0711 topic
  6. Heparin-Induced Thrombocytopenia4761 topic
  7. Thrombosis4761 topic
  8. Deuterium4461 topic
  9. Drug Discovery4461 topic
  10. BRCA Mutation1651 topic
  11. PARP Inhibitors1651 topic
  12. PTPN11671 topic
  13. Protein Tyrosine Phosphatases671 topic
  14. DNA631 topic
  15. Topoisomerases631 topic
  16. Negative Ion Sources91 topic
  17. Superconducting Cavities91 topic

Where does LAURA E. ALDRETE work?

LAURA E. ALDRETE's main affiliation in the publication record is Kenyon College, United States.

How many publications and citations does LAURA E. ALDRETE have?

OpenAlex counts 1,143 works and 34 citations for LAURA E. ALDRETE, an h-index of 2, ranking #7,710,381 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about LAURA E. ALDRETE. Posts are plain text and can be reported.